Existing Aveanna Healthcare (AVAH) holders sell big block of shares
Rhea-AI Filing Summary
Aveanna Healthcare Holdings, Inc. (AVAH) reports that certain existing stockholders completed a secondary public offering of its common stock. On August 20, 2026, the company and the selling stockholders entered into an Underwriting Agreement with RBC Capital Markets, LLC for the sale by those stockholders of 15,000,000 shares of Aveanna common stock at a public offering price of $11.75 per share. The selling stockholders also granted the underwriter a 30‑day option to purchase up to an additional 2,250,000 shares. The secondary offering closed on August 24, 2026. Aveanna did not issue any new shares and did not receive any proceeds from this offering; all proceeds went to the selling stockholders.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Secondary Offering financial
Underwriting Agreement financial
Selling Stockholders financial
public offering price financial
30-day option financial
FAQ
What did Aveanna Healthcare (AVAH) announce regarding its stock on August 24, 2026?
Did Aveanna Healthcare (AVAH) receive any proceeds from the August 2026 secondary offering?
Who acted as underwriter for the Aveanna (AVAH) secondary offering?
When did the Aveanna (AVAH) secondary offering close?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code:
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On August 20, 2026, Aveanna Healthcare Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, certain selling stockholders (the “Selling Stockholders”), including affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and former directors and officers of the Company, and RBC Capital Markets, LLC (the “Underwriter”) with respect to the offer and sale by the Selling Stockholders (the “Secondary Offering”) of 15,000,000 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $11.75 per share. In addition, the Selling Stockholders granted the Underwriter a 30-day option to purchase up to an additional 2,250,000 shares of the Company’s Common Stock. The Secondary Offering closed on August 24, 2026. The Company did not issue or sell any Common Stock in the Secondary Offering and did not receive any proceeds from the Secondary Offering.
The foregoing description of the Underwriting Agreement is qualified in its entirety by the terms of such agreement, which is incorporated herein by reference and attached to this report as Exhibit 1.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit |
||
| 1.1 | Underwriting Agreement, dated August 20, 2026, by and among Aveanna Healthcare Holdings Inc., the selling stockholders named therein, and RBC Capital Markets, LLC | |
| 5.1 | Opinion of King & Spalding LLP | |
| 23.1 | Consent of King & Spalding LLP (included in Exhibit 5.1 above) | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AVEANNA HEALTHCARE HOLDINGS INC. | ||||||
| Date: August 24, 2026 | By: | /s/ Matthew Buckhalter | ||||
| Matthew Buckhalter Chief Financial Officer (Principal Financial Officer) | ||||||